ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Even though nowadays we know how the obesity-related cancer risk may vary depending on multiple factors, such as body site occurrence, fat distribution and adipose-derived profiling, a copious number of studies have largely investigated the Acrp30 role in cancer, even besides the metabolic-related disorders [29].